Key result
Inhibition of the KCNQ1 potassium channel with 100 μM chromanol 293B significantly reduced the acrosome reaction rate of human sperm during capacitation from 35.1% to 29.7%.
Why the study?
The types of potassium channels involved in membrane hyperpolarization and ion homeostasis regulation during human sperm capacitation remain controversial.
Does KCNQ1 inhibition with chromanol 293B reduce sperm motility and acrosome reaction in human sperm during capacitation?
Does KCNQ1 inhibition with chromanol 293B reduce sperm motility and acrosome reaction in human sperm during capacitation?
Absolute Event Rate: 29.7% vs 35.1%
p-value: p=0.017
The KCNQ1 potassium channel is expressed in human sperm, and its inhibition impairs sperm motility, acrosome reaction, and ion homeostasis during capacitation.
May affect sperm fertilizing capacity; leaves open KCNQ1 as a contraceptive or fertility target pending clinical studies.
Potassium channels are involved in membrane hyperpolarization and ion homeostasis regulation during human sperm capacitation. However, the types of potassium channels in human sperm remain controversial. The voltage-gated ion channel KCNQ1 is ubiquitously expressed and regulates key physiological processes in the human body. In the present study, we investigated whether KCNQ1 is expressed in human sperm and what role it might have in sperm function. The expression and localization of KCNQ1 in human sperm were evaluated using Western blotting and indirect immunofluorescence. During capacitation incubation, human sperm were treated with KCNQ1- specific inhibitor chromanol 293B. Sperm motility was analyzed using a computer-assisted sperm analyzer. The acrosome reaction was studied using fluorescein isothiocyanate-conjugated Pisum sativum agglutinin staining. Protein tyrosine phosphorylation levels and localization after capacitation were determined using Western blotting and immunofluorescence. Intracellular K + , Ca 2+ , Cl − , pH, and membrane potential were analyzed using fluorescent probes. The results demonstrate that KCNQ1 is expressed and localized in the head and tail regions of human sperm. KCNQ1 inhibition reduced sperm motility, acrosome reaction rates, and protein tyrosine phosphorylation but had no effect on hyperactivation. KCNQ1 inhibition also increased intracellular K + , membrane potential, and intracellular Cl − , while decreasing intracellular Ca 2+ and pH. In conclusion, the KCNQ1 channel plays a crucial role during human sperm capacitation.
No takes yet. Share an insight, caveat, or question.
Gao et al. (2021) studied Healthy sperm (in vitro capacitation) (n=15). Chromanol 293B vs. Vehicle control (DMSO) was evaluated on Acrosome reaction (AR) ratio (p=0.017). Inhibition of the KCNQ1 potassium channel with 100 μM chromanol 293B significantly reduced the acrosome reaction rate of human sperm during capacitation from 35.1% to 29.7%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: